linsidomine has been researched along with thromboxane a2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benveniste, J; Nunez, D; Russo-Marie, F | 1 |
| Block, HU; Förster, W; Heinroth, I | 1 |
| Armstrong, R; Heptinstall, S; Lösche, W; May, JA | 1 |
| Fujiwara, Y; Gambone, LM; Murray, PA | 1 |
| Fujioka, M; Isaka, N; Ito, M; Miyahara, M; Nakano, T; Nishikawa, M; Shiku, H | 1 |
| Bode-Böger, SM; Böger, RH; Frölich, JC; Galland, A | 1 |
| Murakami, Y; Okuma, Y; Osumi, Y; Yokotani, K | 1 |
1 trial(s) available for linsidomine and thromboxane a2
| Article | Year |
|---|---|
Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
Topics: Adult; Antithrombins; Arginine; Blood Platelets; Cyclic GMP; Enzyme Inhibitors; Humans; In Vitro Techniques; Infusions, Intravenous; Male; Molsidomine; Nitric Oxide Synthase; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Thromboxanes | 1998 |
6 other study(ies) available for linsidomine and thromboxane a2
| Article | Year |
|---|---|
[Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Topics: Animals; Blood Platelets; Molsidomine; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thromboxane A2 | 1987 |
SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Topics: Animals; Arachidonic Acids; Blood Platelets; Drug Interactions; Female; Humans; Indoles; Male; Molsidomine; Oxadiazoles; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Sydnones; Thromboxane A2; Thromboxanes | 1982 |
Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Hirudins; Humans; Iloprost; Magnesium Chloride; Molecular Sequence Data; Molsidomine; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Streptokinase; Thromboxane A2 | 1995 |
Endothelium-dependent pulmonary vasodilation is selectively attenuated during isoflurane anesthesia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthesia; Animals; Blood Pressure; Bradykinin; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Gases; Halothane; Hemodynamics; Homeostasis; Isoflurane; Male; Molsidomine; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1997 |
Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Blood Platelets; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Isoenzymes; Molsidomine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Signal Transduction; Thromboxane A2; Tissue Distribution | 1996 |
Thromboxane A2 is involved in the nitric oxide-induced central activation of adrenomedullary outflow in rats.
Topics: Animals; Benzoates; Cyclooxygenase Inhibitors; Epinephrine; Imidazoles; Indomethacin; Injections, Intraventricular; Male; Medulla Oblongata; Molsidomine; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Receptors, Thromboxane; Superoxide Dismutase; Thromboxane A2; Thromboxane-A Synthase | 1998 |